Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosisDesignation is based on ...

Sanofi SNY announced that the FDA has granted a Breakthrough Therapy designation to its investigational oral BTK inhibitor, ...

French drug major Sanofi (SNY) announced Friday that the U.S. Food and Drug Administration has granted Breakthrough Therapy ...

A new study reveals how a single species of bacteria can sustain a diverse community of phage species, with implications for ...

The investigational oral HER2-specific tyrosine kinase inhibitor would address an unmet need in non–small cell lung cancer.

Vir Biotechnology (NASDAQ:VIR) said its drugs tobevibart and elebsiran have received FDA Breakthrough Therapy designation for the treatment of chronic hepatitis delta. The drugs have also received ...

Deep brain stimulation of the lateral hypothalamus improves walking and promotes recovery in patients with spinal cord injury ...

A pair of studies presented at the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition highlight continuing ...

Months Before C.E.O.’s Killing, the Suspect Went Silent. Where Was He? New details are emerging about Luigi Mangione’s growing impatience with “a capitalist society” and his search for ...

GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval, said the drugmaker this morning. The fast ...

You Can Download iOS 18.2 Today, With ChatGPT, Genmoji, Visual Intelligence for iPhone ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 10, 2024. REUTERS/Brendan McDermid Wall Street pulled back on Thursday as investors evaluated key ...